Bartinsky WS, Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome
Bartinsky WS, Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome
Bartinsky WS, Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome
ORIGINAL
Perfusion in Posterior Reversible Encephalopathy
RESEARCH Syndrome
W.S. Bartynski BACKGROUND AND PURPOSE: The cause of posterior reversible encephalopathy syndrome (PRES) is
J.F. Boardman unknown. Two primary hypotheses exist: 1) hypertension exceeding auto-regulatory limits leading to
forced hyper-perfusion and 2) vasoconstriction and hypo-perfusion leading to ischemia with resultant
edema. The purpose of this study was to evaluate the catheter angiography (CA), MR angiography
(MRA), and MR perfusion (MRP) features in PRES in order to render further insight into its mechanism
of origin.
MATERIALS AND METHODS: In 47 patients with PRES, 9 CAs and 43 MRAs were evaluated for
evidence of vasculopathy (vasoconstriction and vasodilation), and 15 MRP studies were evaluated for
altered relative cerebral blood volume (rCBV) in PRES lesions and regions. Visualization of vessels on
MRA and toxicity blood pressures were compared with the extent of hemispheric vasogenic edema.
BRAIN
N eurotoxicity with development of posterior reversible en-
cephalopathy syndrome (PRES) is commonly seen in as-
sociation with cyclosporine and FK-506 immune suppression
observations on CA, MRA, and MRP could render further
insight into the state of brain perfusion in PRES. Therefore,
the purpose of this study was to retrospectively evaluate the
ORIGINAL RESEARCH
after transplantation (allogeneic bone marrow transplanta- CA, MRA, and MRP features in a large group of patients with
tion [allo-BMT], solid organ transplantation); preeclampsia PRES.
and eclampsia; infection, sepsis, and shock; nonspecific med-
ical renal disease; and in autoimmune conditions as well as Materials and Methods
after high-dose chemotherapy.1-13 The mechanism behind the We searched the radiology report data base at our institution (January
development of PRES is yet unproved. Two broad theories 1998 –October 2006) for patients in whom PRES, cyclosporine,
have generally been considered. tacrolimus, and FK-506 neurotoxicity, hypertensive encephalopathy,
Severe hypertension with autoregulatory failure and hy- systemic lupus erythematosus, Wegener granulomatosis, preeclamp-
perperfusion is often cited as the underlying mechanism. Al- sia and eclampsia, or scleroderma were cited on brain MR imaging.
ternatively, vasospasm has been demonstrated (catheter an- MR imaging studies were reviewed in identified patients for features
giography [CA], MR angiography [MRA]), decreased cerebral consistent with PRES. Criteria included complete or partial expres-
blood flow noted (MR perfusion [MRP], single-photon emis- sion of the typical PRES pattern, reversibility on follow-up imaging,
sion CT [SPECT]) and the imaging appearance typically re- or vasogenic edema as demonstrated by MR diffusion-weighted im-
sembles a watershed distribution suggesting a mechanism re- aging (DWI).
lated to brain hypoperfusion.1-3,5,9,13-20 A total of 116 patients were identified with clinical neurotoxicity
Given these opposing views, it was our opinion that parallel and imaging features consistent with PRES (infection, sepsis, and
shock, 31.4%; transplantation/cyclosporine and FK-506, 31.4%; au-
toimmune disease, 11.4%; postchemotherapy, 5.7%; and eclampsia
Received February 2, 2007; accepted after revision August 13.
or delayed eclampsia, 11.4%). The remaining cases included isolated
From the Department of Radiology, Division of Neuroradiology, University of Pittsburgh,
Presbyterian University Hospital, Pittsburgh, Penn. hypertension and undetermined associations.
Please address correspondence to Walter S. Bartynski, MD, Department of Radiology,
MRA or CA, or both, were available in 47 of these 116 patients,
Division of Neuroradiology, University of Pittsburgh, Presbyterian University Hospital, D132, and in 20 of 47, MRP was also obtained. These 47 patients form the
200 Lothrop St, Pittsburgh, PA 15213; e-mail: [email protected] basis of this retrospective evaluation and report. The Institutional
Indicates article with supplemental on-line tables. Review Board approved this retrospective study.
DOI 10.3174/ajnr.A0839 Inpatient and outpatient records on each patient were compre-
Fig 2. Patient 10 is a 27-year-old man with a history of drug and alcohol abuse with a necrotic pneumonia and empyema
growing Pseudomonas and Klebsiella. He developed altered mentation and an asymmetric neurologic examination with blood
pressures ranging between 130/77 and 130/100 mm Hg. A, Axial MR imaging (FLAIR sequence) demonstrates extensive
vasogenic edema in the occipital lobes (open arrows) and temporooccipital junction (arrowheads) consistent with PRES.
Additional extensive areas of vasogenic edema consistent with PRES judged vasogenic edema grade 4 were present in the
frontal and parietal lobes (not shown). B, Vertebral catheter angiogram obtained after development of occipital hemorrhage
(5 days after initial toxicity) demonstrates areas of vessel narrowing and dilation along with a string-of-bead appearance and areas of focal spasm in parietal and occipital branches of
the PCA. Right common carotid catheter angiogram (not shown) also demonstrated extensive vasospasm in branches of the ACA and MCA. C, MR angiogram obtained 5 days after catheter
angiogram (10 days after initial toxicity) demonstrates persistent vessel irregularity in the posterior cerebral branches (arrows) with a pattern nearly identical to the appearance of the
catheter angiogram. Follow-up MR imaging demonstrated improvement of the extensive vasogenic edema.
demonstrated (MRP, technetium Tc99m hexamethylpropyl- MAP, 140 –160 mm Hg in patients who are normoten-
eneamine oxime single-photon emission CT with a watershed sive).25-29 This seems to be regulated by the endothelium
lesion distribution suggesting hypoperfusion.1-3,5,9,13-20 through effects of elevated transmural pressure and release of
The autoregulatory response is intended to maintain stable thromboxane A2 and endothelin.26 The upper limit is in-
cerebral blood flow in the face of blood pressure fluctua- creased in the setting of essential hypertension and sympa-
tions.25,26 With acute severe hypertension, precapillary arte- thetic stimulation as may exist in patients with cyclosporine
riolar vasoconstriction occurs in small (30 –300 ) resistance toxicity.25,27 Above this upper-threshold MAP, passive vaso-
vessels that limit cerebral blood flow (upper-limit-of-response dilation ensues with subsequent increase in CBF and endothe-
lial fluid transudation.26,27 Vasoconstriction and vasodilation range or is only minimally elevated in 20% to 30% of patients
have been noted in animal studies of acute severe hyperten- with PRES.5
sion, but these changes typically require MAP to exceed 180 to Our results at catheter angiography confirm a high incidence
200 mm Hg.28,29 Although this theory remains popular, tox- of vascular abnormality in PRES (focal vasoconstriction, focal
icity MAP is identified at this critical level (MAP ⬎ 140 –160 vasodilation, and string-of-bead appearance) and demonstrate
mm Hg) in only a small subset of patients who develop PRES. that these observations are reflected in the pattern seen at MRA.
In addition, blood pressure at toxicity is within the normal Results of follow-up MRA demonstrated reversibility of this vas-
lopathy by their confirmation on CA and reversal as docu- vasoconstriction (through autoregulation) and, like a biologic
mented on follow-up MRA studies. Reduced cerebral blood feedback loop, function to worsen hypoperfusion, endothelial
flow as suggested by rCBV could further contribute to per- dysfunction, or endothelial injury.
ceived vessel irregularity on the flow-sensitive 3D TOF MRA Several limitations of our study existed because of the ret-
sequence. More widespread use of advanced technology such rospective nature of this evaluation. Standardized imaging
as 3T MR imaging and intracranial MRA performed during timing and techniques (MRA, MRP, and brain imaging), com-
contrast infusion could markedly improve vessel margin visu- puter modeling of vasogenic edema, broader clinical data re-
alization, reduce flow-related effects, and help augment detec- cording (cytokines), and treatment may be of benefit. It is
tion of these subtle but important vascular features. without doubt that a prospective assessment of PRES would be
important.
PRES and Hypertension
PRES developing and spontaneously reversing in patients who Conclusion
are normotensive suggests a mechanism other than hyperten- CA, MRA, and MRP demonstrate evidence of vasculopathy
sion for the development of vasogenic edema. As graded in our with focal and diffuse vasoconstriction, focal vasodilation, and
study, vasogenic edema in patients with moderate and severe a string-of-bead pattern along with reduced rCBV suggesting a
hypertension was not greater but actually was reduced com- state of brain hypoperfusion in PRES. Vasogenic edema was
pared with patients who were normotensive (P ⫽ .045 be- lower in patients who were hypertensive compared with those
tween patients who were normotensive and those who were who were normotensive (P ⬍ .05). In the patients who were
severely hypertensive). Most patients who were severely hy- severely hypertensive, better PCA visualization correlated
pertensive demonstrated long-segment visualization of the with reduced vasogenic edema (P ⫽ .002).
PCA (despite diffuse vasoconstriction and focal spasm), and in These features suggest that the primary abnormality in
these patients, more lengthy visualization of the PCA (PCA PRES could be related to reduced cerebral blood flow and that
pruning grade 1) was associated with reduced brain edema (P hypertension may, at some level, exert a protective effect lim-
⫽ .002). If failed autoregulation with passive vasodilation and iting the developing of PRES and improving compromised
hyperperfusion were the mechanism in PRES (with or without cerebral perfusion.
endothelial injury), one would expect the opposite observa-
tions including 1) a greater degree of edema in the severe hy-
pertensive group compared with the normotensive group (ac- Acknowledgments
companied by long-segment PCA visualization) and 2) a The authors thank Marcia Kurs-Lasky, MS, for her support
greater degree of vasogenic edema within the severe hyperten- with statistical analysis and Eric Jablonowski for his assistance
sive group in those with greater PCA visualization. with image preparation.
Increased perfusion pressure might, at some point in the
evolving systemic process, help maintain brain blood flow in
the face of increased vascular resistance and hypoxemia, sug- References
gesting a protective effect. Elevated blood pressure and sys- 1. Raroque HG, Orrison WW, Rosenberg GA. Neurologic involvement in tox-
emia of pregnancy: reversible MRI lesions. Neuroradiology 1990;40:167– 69
temic vasoconstriction could be a reactive response (Cushing 2. Truwit CL, Denaro CP, Lake JR, et al. MR imaging of reversible cyclosporin
effect, biocontrol mechanism) designed to maintain adequate A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651–59
organ perfusion at the microvascular level. Of potential im- 3. Bartynski WS, Grabb BC, Zeigler Z, et al. Watershed imaging features and
clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr
portance, severe systemic hypertension developing in the face 1997;21:872– 80
of an increased state of vasoreactivity might augment cerebral 4. Schaefer PW, Buonanno FS, Gonzalez RG, et al. Diffusion-weighted imaging